Indraprastha Medical Corporation Lt

BSE: INDRAMEDCO532150ISIN INE681B01017

Healthcare
Hospital
BSE 1000

Share price

₹337.25+18.05 (+5.65%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹640.05
52W low: ₹293.50
Off 52W high: -47.31%
1M return: +0.94%
3M return: -8.47%
6M return: -19.07%
1Y return: -44.21%
20D avg volume: 9,888
50 DMA: ₹342.37
200 DMA: ₹378.12

Key ratios Standalone

Market cap: ₹3,092 Cr
Current price: ₹337.25
52W high / low: ₹640.05 / ₹293.50
Face value: ₹10.00
P/E: 16.09
P/B: 5.89
EPS (TTM): ₹20.96
Book value / share: ₹57.26
ROE: 36.64%
ROCE: 30.70%
Operating margin: 20.83%
Net margin: 12.98%
Debt / equity: 0.00
Net debt: ₹-4.93 Cr
Interest cover: 41.87
Dividend yield: 1.19%
Dividend / share (TTM): ₹4.00
Payout: 19.08%
Cash conversion cycle: -2.1 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	412.85	406.15	364.81	371.61	381.03	365.06	333.75	324.93	349.82	347.86	314.73	306.46
	8.55	8.42	7.33	7.15	7.37	6.90	6.35	5.13	6.05	5.12	4.89	4.27
	421.40	414.57	372.14	378.76	388.40	371.96	340.10	330.06	355.87	352.98	319.62	310.73
	349.33	339.75	317.13	322.37	322.09	303.65	284.83	285.53	298.94	293.39	278.06	270.06
	67.42	70.13	64.30	63.75	65.45	62.84	59.12	56.18	56.23	58.93	55.54	50.48
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	78.53	72.96	74.18	74.89	73.58	64.95	66.72	72.18	71.61	66.59	64.79	66.48
	1.66	1.65	1.49	1.46	1.51	1.56	1.49	1.58	1.59	1.61	1.56	0.87
	12.26	11.76	11.34	11.25	10.86	10.18	10.91	11.21	11.17	11.04	10.21	10.03
	189.46	183.25	165.82	171.02	170.69	164.12	146.59	58.34	67.18	64.55	65.84	65.15
	72.07	74.82	55.01	56.39	66.31	68.31	55.27	44.53	56.93	59.59	41.56	40.67
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	72.07	74.82	55.01	56.39	66.31	68.31	55.27	44.53	56.93	59.59	41.56	40.67
	18.49	18.97	13.31	15.39	16.85	16.85	14.26	11.72	14.53	14.82	10.39	11.23
	53.58	55.85	41.70	41.00	49.46	51.46	41.01	32.81	42.40	44.77	31.17	29.44
	5.84	6.09	4.55	4.47	5.40	5.61	4.47	3.58	4.63	4.88	3.40	3.21
Key metrics
	85.99	88.23	67.84	69.10	78.68	80.05	67.67	57.32	69.69	72.24	53.33	51.57
	20.80%	21.70%	18.60%	18.60%	20.60%	21.90%	20.30%	17.60%	19.90%	20.80%	16.90%	16.80%
	13.00%	13.80%	11.40%	11.00%	13.00%	14.10%	12.30%	10.10%	12.10%	12.90%	9.90%	9.60%
	8.20%	—	6.90%	—	9.30%	—	8.40%	—	—	—	—	—
	8.40%	11.30%	9.30%	14.40%	8.90%	4.90%	6.00%	6.00%	—	—	—	—
	8.30%	8.50%	1.70%	25.00%	16.70%	14.90%	31.60%	11.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,555	1,483	1,356	1,245	1,099	888.16
	31.45	28.75	22.65	16.89	10.03	3.12
	1,587	1,511	1,379	1,262	1,109	891.28
	1,329	1,265	1,163	1,095	991.52	812.21
	265.60	256.34	230.46	217.19	193.61	173.72
	0.00	0.00	0.00	—	—	—
	300.56	287.60	277.10	261.61	246.70	214.68
	6.26	6.02	6.27	4.06	4.28	3.41
	46.61	43.63	44.33	40.08	39.27	34.94
	709.55	671.65	604.53	260.75	227.11	175.94
	258.29	246.02	216.32	166.11	117.18	79.07
	0.00	0.00	0.00	—	—	—
	258.29	246.02	216.32	166.11	117.18	79.07
	66.16	62.40	55.33	42.15	31.03	20.45
	192.13	183.62	160.99	123.96	86.15	58.62
	20.95	20.03	17.56	13.52	9.40	6.39
Key metrics
	311.16	295.67	266.92	210.25	160.73	117.42
	20.00%	19.90%	19.70%	16.90%	14.60%	13.20%
	12.35%	12.40%	11.90%	10.00%	7.80%	6.60%
	—	30.70%	33.10%	—	—	—
	10.72%	9.30%	9.00%	13.30%	23.70%	—
	9.95%	14.10%	29.90%	43.90%	47.00%	—
	—	107.79	120.42	—	—	—
	—	0.91	0.97	—	—	—
	—	0.00	0.00	—	—	—
	—	-4.93	-61.48	—	—	—
	—	-2.1	-10.8	—	—	—
Balance sheet
	—	991.36	851.62	—	—	—
	—	416.59	431.13	—	—	—
	—	4.93	61.48	—	—	—
	—	112.16	75.45	—	—	—
	—	7.86	6.99	—	—	—
	—	12.28	16.60	—	—	—
	—	364.48	327.47	—	—	—
	—	128.15	122.54	—	—	—
	—	169.55	178.71	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	740.37	596.68	—	—	—
Cash flow
	—	167.44	156.75	—	—	—
	—	-177.61	-110.99	—	—	—
	—	-46.38	-45.88	—	—	—
	—	59.65	36.33	—	—	—

Compounded growth

Sales CAGR 3Y: +10.50%
Sales CAGR 5Y: —
Profit CAGR 3Y: +28.69%
Profit CAGR 5Y: —
Sales YoY (TTM): +10.72%
Profit YoY (TTM): +9.95%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 51.00%

Quarter	September 2026	June 2026
Promoter %	51.00%	51.00%

Holder	Type	Holding	Previous	Change
PRESIDENT OF INDIA	Promoter	26.00%	26.00%	0.00%
APOLLO HOSPITALS ENTERPRISE LIMITED	Promoter	22.02%	—	—
EMEDLIFE INSURANCE BROKING SERVICES LIMITED	Public	1.70%	1.70%	0.00%
WEDGEWOOD HOLDINGS LIMITED	Promoter Group	1.61%	1.61%	0.00%
CITADEL RESEARCH AND SOLUTIONS LIMITED	Public	1.29%	1.29%	0.00%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS	Public	1.07%	—	—
PCR INVESTMENTS LIMITED	Promoter Group	0.42%	—	—
PRATAP C REDDY	Promoter	0.26%	0.26%	0.00%
PREETHA REDDY	Promoter	0.22%	0.22%	0.00%
SUCHARITHA P REDDY	Promoter	0.18%	0.18%	0.00%
SUNEETA REDDY	Promoter	0.15%	0.15%	0.00%
SHOBHANA KAMINENI	Promoter	0.13%	—	—
SANGiTA REDDY	Promoter	0.01%	0.01%	0.00%
K S BAIDWAN	Promoter	0.00%	0.00%	0.00%
VINEETA RAI	Promoter	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

We hereby submit copies of the public notice of the financial results published on 30th October 2026, in the Financial Express all India edition in English language and in Jansatta Delhi ....30 Oct 2026 · Company Update / Newspaper Publication
We are enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended 30th September 2026, along with a copy of the Limited Review Report by the Statutory Auditors ....29 Oct 2026 · Board Meeting / Outcome of Board Meeting
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve It is hereby ....19 Oct 2026 · Board Meeting / Board Meeting
We hereby submits a certificate dated 6th October 2026, issued by M/s MUFG Intime India Private Limited, Register Transfer Agent of the company,.14 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The 38th AGM of the company was held on 24th September, 2026 through VC and OAVM and the buisness mentioned in the notice dated 6th August, 2026 was transacted. Enclosed please find the ....25 Sep 2026 · AGM/EGM / AGM
We hereby submit per annexure summary of the proceedings of the 38th AGM of the Company held on 24th September, 2026, through video confrencing and other audio- visual means.24 Sep 2026 · AGM/EGM / AGM
The Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected ....22 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
we hereby submit the copies of public notice for transfer of shares to IEPF, published on 15th September,2026 in the Financial Express, all India edition in English Language and in Jansatta, ....15 Sep 2026 · Company Update / Newspaper Publication
we hereby submit copies of the public notice of the 38th AGM, published in the finacial express all India editions in english language and in jansatta delhi edition in hindi language3 Sep 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 34(1)(a) & 53(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Annual Report of the Company for the financial year ended 31st ....1 Sep 2026 · Others / Reg. 34 (1) Annual Report
Enclosed please find the Annual Report of the company for the financial year ended 31st March, 2026 along with the notice of the 38th AGM , to be held on 24th September, 2026, and, Business ....1 Sep 2026 · AGM/EGM / AGM
1)The AGM of the Company will be held on Thursday, 24th September, 2026. 2) The Record date for purpose of declaration of Dividend is 18th September, 2026. 3) The cut-off date for ....29 Aug 2026 · Company Update / General
we hereby submit copies of the public notice of the Financial results , published on 7th August, 2026, in the "Financial Express", all India Editions, in English Language and in " Jansatta", ....7 Aug 2026 · Company Update / Newspaper Publication
The board of directors of the company has at its meeting held on 6th August, 2026 considered and approved convening the 38th AGM of the company on 24th September, 2026 through Video Conferencing\ ....6 Aug 2026 · Company Update / General
The board of director of the company as its meeting held on 06-08-2026 considered and approved fixation of record date as Friday 18-09-2026 for the purpose of payment of dividend for the ....6 Aug 2026 · Corp. Action / Record Date
This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following items: ....6 Aug 2026 · Board Meeting / Outcome of Board Meeting
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve It is hereby ....27 Jul 2026 · Board Meeting / Board Meeting
Enclosed please find herewith a certificate dated 6th July,2026 issued M/s MUFG Intime india Private Limited Registrar And Share transfer agent of the company quarter ended 30th June, 2026.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
it is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons from Wednesday 1 st July, 2026 till 48 hours after the ....24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
We wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June, 2026 & 5th June, 2026 at Mumbai. Further, please note ....2 Jun 2026 · Company Update / Analyst / Investor Meet
we wish to inform you that ICRA Limited has vide its letter dated 26th May, 2026, re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation ....27 May 2026 · Company Update / Credit Rating
We hereby submit copies of the public notice of the financial results, published on 13th May, 2026, in the "Financial Express", all India editions, in English Language and in " Jansatta", ....13 May 2026 · Company Update / Newspaper Publication
the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March, 2026, 2. Reccomended a dividend @ 40% i.e., Rs 4 per ....12 May 2026 · Board Meeting / Outcome of Board Meeting
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Pursuant to ....1 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....23 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Please find herewith a certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st March, 2026.7 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, in the ....7 Apr 2026 · Company Update / Newspaper Publication
We hereby inform you that Mr. Vinayak Chatterjee (DIN: 00008933) has completed his tenure viz. second term of five consecutive years on 31st March, 2026, as Independent Director on the ....1 Apr 2026 · Company Update / Change in Management
We wish to inform you that financial results for the quarter and year ending on 31st March, 2026, along with other matters for which trading window is required to be closed from Wednesday, ....24 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
We hereby submit, voting results of the Postal Ballot Notice dated 3rd February 2026, along with copy of the Scrutinizer report dated 21st march 202621 Mar 2026 · AGM/EGM / Postal Ballot
We hereby submit copies of the public notice of the postal Ballot published on 20th Februrary 2026 in the Financial Express all India Editions and in Jansatta Delhi edition.20 Feb 2026 · Company Update / Newspaper Publication
Enclosed please find notice for Postal ballot. Seeking approvals of shareholders for appointment/ reappointment of independent directors as per details given in attached notice of postal ballot.18 Feb 2026 · AGM/EGM / Postal Ballot
We hereby submits the copy of public notice of financial results published on 4th February, 2026 in Financial Express all India editions in English language and in Jansatta Delhi edition ....4 Feb 2026 · Company Update / Newspaper Publication
It is hereby informed the board of directors in its meeting held on 03.02.2026, considered and approved the appionment/ re-appiontment of the following : 1. Mr. Harsh Pati Singhania as ....3 Feb 2026 · Company Update / Change in Management
Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board of Directors of the Company at its meeting ....3 Feb 2026 · Board Meeting / Outcome of Board Meeting
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve It is hereby ....19 Jan 2026 · Board Meeting / Board Meeting
Enclosed please find herewith a certificate dated 9/01/2026 issued by M/s MUFG Intime India Pvt Ltd, registrar and share transfer agent of the company for the quarter ended 31/12/2025.14 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We wish to inform you that the trading window of the company will remain closed from 1st January, 2026 till 48 hours after announcement / declaration of unaudited financial results for ....19 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
we wish to submit that the management of the company intends to participate in the "annual flagship Conference- Anand Rathi G-200 Submit on 13th November, 2025 at Mumbai.10 Nov 2025 · Company Update / Analyst / Investor Meet
We hereby submit copies of the public notice of the financial results, published on 3rd November, 2025, in the "Financial Express", all India editions, in English language and in "Jansatta", ....3 Nov 2025 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 4.0000	18 Sep 2026	18 Sep 2026	—
Final Dividend - Rs. - 4.5000	18 Sep 2025	18 Sep 2025	—
Final Dividend - Rs. - 4.5000	13 Sep 2024	—	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
6 Aug 2026 Board Meeting - Financial Results